196 related articles for article (PubMed ID: 2918041)
1. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
Riss TL; Sirbasku DA
J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041
[TBL] [Abstract][Full Text] [Related]
2. Characterization of polyclonal antibodies that distinguish acidic and basic fibroblast growth factors by using western immunoblotting and enzyme-linked immunosorbent assays.
Riss TL; Sirbasku DA
J Cell Physiol; 1989 Feb; 138(2):405-14. PubMed ID: 2918042
[TBL] [Abstract][Full Text] [Related]
3. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
4. Presence of growth factors in human pituitary.
Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
6. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
8. Factors in the rat submaxillary gland that stimulate growth of cultured glioma cells: identification and partial characterization.
McClure DB; Ohasa S; Sato GH
J Cell Physiol; 1981 May; 107(2):195-207. PubMed ID: 6972945
[TBL] [Abstract][Full Text] [Related]
9. Growth and continuous passage of COMMA-D mouse mammary epithelial cells in hormonally defined serum-free medium.
Riss TL; Sirbasku DA
Cancer Res; 1987 Jul; 47(14):3776-82. PubMed ID: 3297308
[TBL] [Abstract][Full Text] [Related]
10. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
11. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
12. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
13. [A transforming growth factor-beta like growth factor in mouse embryonal carcinoma cells].
Shi WK; Yao Z
Shi Yan Sheng Wu Xue Bao; 1989 Jun; 22(2):213-23. PubMed ID: 2800839
[TBL] [Abstract][Full Text] [Related]
14. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
Zarnegar R; Michalopoulos G
Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
[TBL] [Abstract][Full Text] [Related]
15. Assessment of biological activity of linear alpha-transforming growth factor and monospecific antibodies to alpha-transforming growth factor and linear alpha-transforming growth factor.
Hanauske AR; Buchok JB; Pardue RL; Muggia VA; Von Hoff DD
Cancer Res; 1986 Nov; 46(11):5567-70. PubMed ID: 3463415
[TBL] [Abstract][Full Text] [Related]
16. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
17. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.
Sanfilippo JS; Rao CV; Guarnaschelli JJ; Woost PG; Byrd VM; Jones E; Schultz GS
Surg Gynecol Obstet; 1993 Nov; 177(5):488-96. PubMed ID: 8211601
[TBL] [Abstract][Full Text] [Related]
18. Identification of alpha transforming growth factor as a possible local trophic agent for the mammary gland.
Smith JA; Barraclough R; Fernig DG; Rudland PS
J Cell Physiol; 1989 Nov; 141(2):362-70. PubMed ID: 2808543
[TBL] [Abstract][Full Text] [Related]
19. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
20. Identification of extractable growth factors from small intestinal submucosa.
Voytik-Harbin SL; Brightman AO; Kraine MR; Waisner B; Badylak SF
J Cell Biochem; 1997 Dec; 67(4):478-91. PubMed ID: 9383707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
